These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9123373)

  • 1. Presensitization and HLA match influence the predictive power of pretransplant serum IgA and IgA-anti-Fab autoantibodies in kidney graft recipients.
    Süsal C; Wiesel M; Schönemann C; Groth J; Carl S; Staehler G; May G; Opelz G
    Transplant Proc; 1997; 29(1-2):1444-6. PubMed ID: 9123373
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity as prognostic indicators of kidney graft survival.
    Süsal C; Dörr C; Groth J; May G; Opelz G
    Transpl Int; 1994; 7 Suppl 1():S586-9. PubMed ID: 11271315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excellent kidney graft survival in patients with high pretransplant serum IgA concentrations and IgA-anti-Fab autoantibody activity.
    Süsal C; Wiesel M; Staehler G; Groth J; May G; Opelz G
    Transplant Proc; 1995 Feb; 27(1):1072-4. PubMed ID: 7878810
    [No Abstract]   [Full Text] [Related]  

  • 4. Allocation of cadaver kidneys according to HLA-DR matching alone would result in optimal graft outcome in most recipients.
    Vereerstraeten P; Abramowicz D; Andrien M; Dupont E; De Pauw L; Kinnaert P
    Transplant Proc; 1999; 31(1-2):739-41. PubMed ID: 10083315
    [No Abstract]   [Full Text] [Related]  

  • 5. IgA class antibodies and flow cytometric cross-matching in renal transplantation.
    Doran TJ; Süsal C; Opelz G; Geczy AF
    Transplantation; 1999 Jan; 67(2):309-14. PubMed ID: 10075600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplant IgA-anti-hinge and IgA-anti-Fab autoantibody activity is associated with good kidney graft survival.
    Süsal C; Kröpelin M; Wiesel M; Staehler G; Groth J; May G; Opelz G
    Transplant Proc; 1995 Oct; 27(5):2663-5. PubMed ID: 7482869
    [No Abstract]   [Full Text] [Related]  

  • 8. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity in living donor renal transplant recipients: a pilot study.
    Kim MS; Kim YS; Kim SI; Lee JW; Moon JI; Park K
    Transplant Proc; 1998 Nov; 30(7):2977-8. PubMed ID: 9838314
    [No Abstract]   [Full Text] [Related]  

  • 9. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies.
    Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Mohammadiazar S; Solgi G
    Hum Immunol; 2014 Jan; 75(1):47-58. PubMed ID: 24055694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E; Berthoux F; Acquart S; Lepetit JC
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients.
    Reisaeter AV; Leivestad T; Fauchald P; Brekke I; Thorsby E
    Transplant Proc; 1997 Nov; 29(7):3099-100. PubMed ID: 9365682
    [No Abstract]   [Full Text] [Related]  

  • 12. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of HLA A,B,C, matching on graft survival, patient survival, and graft function in living related renal transplant patients treated with cyclosporine.
    Masri MA; Dhawan IK; Hayes K; Zahir M; Shanwaz M; Shakuntala S; Pingle A
    Transplant Proc; 1992 Oct; 24(5):1676-7. PubMed ID: 1412793
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerance induction in human kidney retransplantation: impact of repeated HLA mismatches in 156 second renal grafts.
    Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):319-21. PubMed ID: 8438317
    [No Abstract]   [Full Text] [Related]  

  • 15. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine: has it made a difference between using HLA or not? A comparative study between patients with and without HLA matching.
    Juarez F; Barrios Y; Cano L; Chavez E; Camacho R; Gomez A; Maciel M; Borjon S; Limones M; Peniche L
    Transplant Proc; 1998 Aug; 30(5):1744-5. PubMed ID: 9723263
    [No Abstract]   [Full Text] [Related]  

  • 17. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
    MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA
    Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of recipient's HLA type on the outcome of renal transplantation.
    Forsberg B; Ekberg H; Johnson U
    Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z; Adam K; Parapanissiou E; Sakellariou G; Papakyriazi E; Antoniadis A; Papadimitriou M
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategy for improving retransplantation in the CyA era.
    Dickerman R; Langley J; Brinker K; Trevino G; Melton L; Vergne-Marini P; Wilson PK
    Transplant Proc; 1993 Feb; 25(1 Pt 1):257-8. PubMed ID: 8438292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.